VIRTUAL EVENT
SCB will hosting a webinar to discuss the recently released FDA guidance on CBER's Voluntary Consensus Standards Recognition Program for Regenerative Medicine Therapies. In this webinar, SCB will explain the draft guidance document and collect and coordinate participant comments for submission to the FDA.
WEBINAR SPONSORED BY:
